Peripheral Blood Mononuclear Cells Market to Grow with a CAGR of 10.02% through 2030
Increased number of cell
therapies for human well-being is expected to drive the growth of global
peripheral blood mononuclear cells market in the forecast period, 2026-2030.
According to TechSci Research
report, “Peripheral Blood Mononuclear Cells Market - Global Industry
Size, Share, Trends, Opportunity, and Forecast, 2020-2030F”, the Global Peripheral Blood Mononuclear Cells Market was valued at USD 280.89 million in 2024 and is expected to reach USD 496.02 million by 2030 with a CAGR of 10.02% during the forecast period. The major factors driving the
growth of Peripheral Blood Mononuclear Cells Market include increase in number
of cell therapies, growing R&D of peripheral blood mononuclear cells and
growing usage of peripheral cells in toxicology research.
The peripheral blood mononuclear
cells (PBMCs) are used to investigate the effect of food bio-actives on various
immune cells. They have a round nucleus, consisting of macrophages, dendritic
cells, monocytes, and lymphocytes (T cells, B cells, and NK cells). However,
these cells prevent the body by developing antibodies against antigens.
However, one of the restraining
factors is ethical and legal considerations. The acquisition of PBMCs involves
obtaining blood samples from donors, which raises ethical and legal
considerations. Consent from donors, compliance with ethical guidelines, and
adherence to privacy regulations are essential. Strict regulatory frameworks
and ethical concerns can impose limitations on the collection, storage, and
utilization of PBMCs, potentially hindering the growth of global peripheral
blood mononuclear cells market. Also, the cost of PBMC isolation and processing
is high. The isolation, processing, and storage of PBMCs involve significant
costs. Specialized equipment, reagents, and skilled personnel are required for
these procedures. Moreover, maintaining optimal storage conditions, such as
low-temperature freezers, can further increase the costs.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Peripheral Blood Mononuclear Cells Market"
The global peripheral blood
mononuclear cells market is segmented into product, application, technique,
source, regional distribution, and company.
Based on Application, Immunology is the fastest-growing application segment. This surge is primarily driven by the increasing demand for immunological research related to autoimmune diseases, cancer immunotherapy, vaccine development, and chronic inflammatory disorders. PBMCs play a vital role in immunology because they include lymphocytes (T cells, B cells, NK cells) and monocytes—critical components of the immune system used in both basic and translational research. The rise in global autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis, has intensified the need for immune profiling studies using PBMCs. Additionally, immuno-oncology has emerged as a dominant force in cancer research, with therapies like CAR-T cells and immune checkpoint inhibitors relying heavily on immune cell studies derived from PBMCs. The use of PBMCs in flow cytometry, ELISpot, and cytokine release assays has become standard for evaluating immune responses. The COVID-19 pandemic further accelerated this growth by spotlighting the importance of understanding host immune responses to viral infections. Researchers worldwide used PBMCs to study T-cell responses in infected and vaccinated individuals, strengthening the role of PBMCs in infectious and immunological studies.
Based on the Region, The Asia Pacific region is witnessing the fastest growth in the global Peripheral Blood Mononuclear Cells (PBMCs) market. This surge is attributed to expanding biomedical research, growing investments in healthcare infrastructure, and rising awareness of immunology and regenerative medicine. Countries like China, India, South Korea, and Japan are increasingly focusing on precision medicine, vaccine development, and cancer immunotherapy, which rely heavily on PBMCs. Additionally, government initiatives to boost biotechnology and life sciences research—such as India’s Department of Biotechnology (DBT) programs and China’s 14th Five-Year Plan promoting biotech innovation—are accelerating market growth. Cost-effective clinical trials and increasing collaboration with global pharmaceutical companies also contribute to the region's momentum.
The leading companies operating
in the Global Peripheral Blood Mononuclear Cells Market are:
- Charles River Laboratories International, Inc.
- Lonza Group AG
- Corning Inc.
- Bio-Rad Laboratories Inc.
- ABCAM
- Biolegend Inc.
- ZEN-Bio Inc.
- DAPCEL, Inc.
- Creative Bioarray
- iXCells Biotechnologies USA, LLC
Download Free Sample Report
Customers can also request for
10% free customization on this report.
“Global peripheral blood
mononuclear cells market will see a robust growth during the forecast period. The market for peripheral blood mononuclear cells is expected to
develop due to rising research practices, cell-based therapies to either
replace or regenerate human cells, tissues, or organs for normal functioning,
and increased focus on regenerative medicine. Additionally, the global
peripheral blood mononuclear cells market has been fueled by advancements in
technology, therapies, and treatments, rising research in Biotechnology and
Cell Culture Techniques, supportive government initiatives, and funding.”, said
Mr. Karan Chechi, Research Director of TechSci Research, a research based
global management consulting firm.
“Peripheral Blood Mononuclear Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC, and Peripheral Blood Mononuclear Cell Isolation & Viability Kits), By Application (Immunology, Hematology, Infectious Disease, Hematology, and Others), By Techniques (Density Gradient Centrifugation, Leukapheresis, and Others), By Source (Human, Animals), By Region and Competition, 2020-2030F”, has
evaluated the future growth potential of Global Peripheral Blood Mononuclear
Cells Market and provides statistics & information on market size,
structure, and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Peripheral Blood
Mononuclear Cells Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com